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Abstract 
 Brucella species, BVDV and BHV-1 are important worldwide pathogens that primarily 
infect cattle and other ruminants and are associated with serious economic impact to the 
animal production sector. Camels are indispensable domesticated animals for the people of 
desert areas, such as the Arabian Peninsula, and share the same environment and pasture 
with cattle, goats, sheep and other ruminants, which increase the likelihood of exposure to 
these pathogens. The investigation presented in this thesis was a serological survey 
conducted in Al-Ain region of the United Arab Emirates (UAE), and was designed to 
determine the presence of antibodies against Brucella species, BVDV and BHV-1. Serum 
samples from 812 camels of both sexes, and different ages were collected from the local 
central abattoir, the camel market and 10 private farms. A commercial competitive ELISA 
was used to determine the presence of Brucella abortus antibodies, and a blocking ELISA, 
was used for the detection of antibodies to BVDV and BHV-1. 
 Samples with suspected or non-specific positive results, were retested with confirmatory 
tests such as Complement Fixation and Virus Neutralization test, as required. No sera from 
the 812 camels in this study tested positive for any of the three pathogens. 
 Without underestimating the progress and efforts of the local veterinary authorities, these 
results indicate the need for more extensive sampling and comprehensive surveys on a 
systematic epidemiological basis and including other pathogens. It is also necessary to 
reconsider the criteria for performance and validation of the assays used. This will lead to a 
better understanding of the pathogenesis of the agents involved, and consequently enhance 
knowledge to improve existing control and eradication programmes of infectious diseases 
in camels. 
 
Keywords: camels, C-ELISA, B-ELISA, Brucella abortus, BVDV, BHV-1. United 
Arab Emirates 
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Abbreviations 
B. abortus Brucella abortus 
BHV-1 Bovine herpesvirus-1 
BVDV  Bovine viral diarrhoea virus 
ELISA Enzyme-linked immunosorbent assay 
B-ELISA Blocking ELISA 
C- ELISA Competitive ELISA  
cp Cytopathic 
CPE Cytopathic effect 
CFT Complement fixation test   
IBP Infectious balanoposthitis 
IBR  Infectious bovine rhinotracheitis  
IPV Infectious pustular vulvovaginitis 
IPX Immuno peroxidase 
mABs Monoclonal antibodies  
MD Mucosal disease 
ncp Non-cytopathic  
NWC New world camels 
OD Optical density  
OWC Old world camels 
PCR Polymerase chain reaction 
PI Persistently infected  
RNA Ribonucleic acid 
S-LPS Smooth lipopolysaccaride 
RT-PCR Reverse transcriptase polymerase chain reaction 
UAE United Arab Emirates 
VI  Virus isolation 
VNT Virus neutralization test 
Background 
 The United Arab Emirates is located in the northern-eastern corner of the 
Arabian Peninsula, boarded by the Arabian Sea, Saudi Arabia, Qatar and Oman. 
Approximately, 65% of the total country area is occupied by desert, a suitable 
habitat for camel species. 
 
Map of the United Arab Emirates 
 
Source: http://www.lib.utexas.edu/ 
 
 Single humped camels (Camelus Dromedarius) and the two humped camels 
(Camelus Bactrianus) are defined as Old World Camels (OWC), whereas the 
camelids from South America (llamas, alpacas, vicuñas and guanacos) are defined 
as the New World Camels (NWC). In the Arab Gulf states, dromedaries re an 
essential source of human food, transportation and entertainment. Improvements 
in management methods and provision of efficient veterinary services have 
effectively preserved the number of camels and consequently their potential as an 
additional source of wool, milk and meat (reviewed by Wernery & Kaaden 1995). 
 
 Camels have been endowed with particular anatomical and physiological traits, 
and a relatively low susceptibility to a wide range of diseases (Wernery & Kaaden, 
1995). This has provided them with endurance for survival and to undertake 
difficult tasks: they are the most suitable pack animal for multipurpose use in the 
harsh climate prevailing in the region. Ownership of healthy camel herds offers a 
remarkable social reputation and dignity (Kumar, 2001). 
 The uniqueness of camel reproductive characteristics are evident in their 
epithelio-chorial diffused placenta, and the exclusive location of pregnancy at the 
8-15 cm long left horn of its Tshaped bicornate uterus (Kuhad et al., 2001). The 
uterus has a body of smooth endometrium 2-3 cm in length. The ovaries are 
flattened lobulated structures, enclosed in conical-shaped ovarian bursa, with 
apexes leading to the oviducts. Camels are induced ovulators, and ovarian activity 
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is mainly follicular. The Corpora lutae is present exclusively during the 14-month 
long pregnancy. Single foetus pregnancy is the rule, with twin pregnancy a rare 
event (Musa & Abu Sineina, 1976; Kumar et al., 2001; Skidmore, 2002). 
 
 Due to their confinement in remote areas far from urban centres, the camel’s 
susceptibility to a number of bacterial and viral diseases infecting other ruminants 
e.g. tuberculosis, Foot and Mouth disease (FMD), and abortion causing pathogens 
e.g. Brucella, Bovine Viral Diarrhoea Virus (BVDV) and Bovine Herpes Virus-1 
(BHV-1), was minimal, (Bitter, 1986). Socio-economical developments have 
imposed a great shift to pastoralist life-style and brought them and their camels 
nearer to urban areas (Hjort, 1988). Reproductive failure in camels has been 
reported in the region, and Toxoplasma gondii, Chlamydia spp. and leptospira-like 
organisms have been isolated (Wernery & Kaaden, 1995). Uterine smears and 
biopsies, as well as serology, represent an invaluable source for studying genital 
infections in camels that result in reduced fertility or foetal death with or without 
abortion (Wernery & Kaaden, 1995). The scarcity of essential and reliable data on 
the prevalence of Brucella abortus, BVDVand BHV-1 in camels has been a major 
hindrance for establishing appropriate schemes for control of these diseases. 
 
Study of literature 
1. Brucella abortus 
Epidemiology and pathogenesis 
 The members of Brucella genus are the etiological agents of brucellosis, which 
is a worldwide important zoonotic disease, except in developed countries where 
national eradication plans have been successfully adopted. Brucella spp are 
pathogens that directly cause heavy economic losses to the animal production 
industry due to abortion, delayed or persistent infertility, drop in milk production, 
and culling of infected animals (For review see: Nielsen & Duncan 1990). 
Brucellosis is geographically widespread infection. Prevalence figures from 
various countries are presented in Table 1.  
Brucella spp are obligate parasites requiring reservoirs for maintenance, which is 
clearly noticed in the susceptible broad host spectrum. However, major Brucella 
spp. exhibit host preference, such as: B. abortus (cattle), B. melitensis (goats), B. 
ovis (sheep), B. suis (pigs), B. canis (dog), B. neotome (desert or wood rats), and 
B. maris (marine mammals). In addition, the organism establishes chronic 
infections in game species and wild ruminants that increase the spreading potential 
of the disease. Brucellosis is of public health concern., as humans are considered 
the end hosts of B. abortus associated with a moderately severe infection, known 
as “undulant fever”, and B. melitensis, B. canis and B. suis cause the much more 
severe disease known as “Malta fever” (For review see Quinn et al., 2002). 
 
 Several physical and biochemical characteristics such as colonial morphology, 
metabolic patterns, culture requirements, and dyes and phages susceptibility are 
used for the identification and biotyping of species and biovars. Brucella abortus 
has been isolated from at least nine species of domestic animals, and has nine 
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biotypes, although another 22 are reported, which indicates a degree of genetic 
plasticity (Farrell & Robertson, 1967; Salem, 1987). 
 Brucella spp. are small gram negative, non-motile, non-spore-forming 
facultative intracellular coccobacilli. They are also aerobic, carboxyphylic, non-
haemolytic, catalase, urease and oxidase-positive, and non-fermenters of sugar. 
Virulent strains form smooth colonies and have different surface antigens. The 
loss of virulence is associated with the transformation of smooth colonies into 
rough ones (Roope et al., 1991;Carter et al., 1995; Carter et al., 2004). 
Cattle of all ages are susceptible to B. abortus, however, sexually mature animals 
and pregnant dairy cattle are most commonly affected, compared to young animals 
that acquire the pathogen either in utero or postnatally (Fensterbank, 1978; 
Crawford et al., 1986; Ray et al., 1988). 
 The reticulo-endothelial system and the reproductive tract are sites of 
predilection for B. abortus. During late gestation, the disease is characterized by 
abortion in non-vaccinated heifers. Orchitis, epididymitis, seminal vasculitis, with 
impaired fertility, are the usual clinical observations in bulls. B. abortus infection 
occurs in the oral mucosa or naso-pharynx through ingestion or inhalation: 
occasionally infection is through the conjunctivae or genitalia. From the portal of 
entry, the pathogen is transported either free or within the phagocytes to regional 
lymph nodes, and is then followed by augmented replication in the macrophages 
and haematogenous dissemination (Ko & Splitter, 2003). The marked capacity for 
intracellular survival is crucial for the pathogenicity of the microorganism: 
Brucella spp interfere with phagocyte function, avoid the intraphagocytic killing 
mechanisms, and are protected from the immune system, humoral and cellular 
bactericidal mechanisms. Consequently, an extensive localization of the bacteria 
occurs in bone marrow, mammary glands and sexual organs accompanied by 
formation of granulomatous foci that may abscess. After abortion the udder may 
persistently harbour the infectious bacteria, generating a focus for udder-
originated bacteraemia that repeatedly invades the gravid uterus in each following 
pregnancy (for review see Radostits & Arundel, 2000) 
 The pathogenesis of the disease is governed by the degree of virulence, the 
magnitude of the infecting dose, and host susceptibility. The introduction of 
animals of unknown origin and disease status into a disease-free herd is associated 
with inter-herd transmission; whereas, the intra-herd spread is facilitated by 
horizontal as well as vertical transmission (For review see: Crawford et al., 1990; 
Price et al., 1990). 
 
 Camels are considered susceptible to B. abortus infection, especially when they 
are in contact with infected large or small ruminants. The incidence and 
prevalence of brucellosis in camels has been clearly related to breeding and 
husbandry practices; therefore, a low prevalence has been associated with nomadic 
or extensively kept pastoralist camels, and a higher prevalence has been associated 
with intensive or semi-intensive management systems (Richard, 1980; Abbas & 
Agab, 2002). 
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Diagnosis 
 Accurate diagnosis of brucellosis is achieved by laboratory methods, as 
abortion, the sole suggestive clinical sign, is not pathognomonic. The detection of 
the microorganism is by direct examination of the clinical specimens through 
conventional staining or immunohistochemistry (IHC), followed by isolation and 
identification of the microorganism (For review see: Carter et al., 1995). Aborted 
foetuses, placenta, uterine exudates, testicular and epididymal abscesses, which 
contain appreciable quantities of the infectious brucella, are materials 
recommended for laboratory diagnosis. When positive cultures are not observed, 
serological tests are essential for a presumptive diagnosis (Nielsen & Duncan, 
1988). Serological procedures are used for detecting the presence of antibodies in 
blood, milk, whey, vaginal mucus, seminal plasma or muscle extracts. Numerous 
tests with varying degrees of specificity and sensitivity are available, but many are 
no longer in use. The plate or tube serum agglutination tests (SAT), Rose Bengal 
plate test (RBPT), buffered plate antigen (BPAT) or card test, and the Milk Ring 
Test (MRT) are classic sensitive screening tests. The highly specific 
mercaptoethanol (2-MER), complement fixation tests, and different ELISA 
formats are described as supplementary and confirmatory, although part of the 
tests are also applicable for screening purposes (Angus & Barton, 1984; 
Radostits& Arundel, 2000). 
 
The Complement Fixation Test (CFT)  
 The CFT is of the highest specificity and is considered as a definitive diagnostic 
test after organism isolation. Sheep red blood cells, rabbit anti-sheep sera, and 
guinea pig serum, as sources of active complement, are the basic reagents 
employed. False negative reaction occurs with a single dilution or the presence of 
excess IgG2 and is associated with the so-called, pro-zoning phenomenon. 
Another drawback is the inefficiency in detecting 2% of culture positive animals at 
abortion. However, automation of the test has provided a practical solution to the 
technical difficulties associated with the test (For Review see Nielsen and Duncan, 
1990). 
 
Enzyme Linked Immunosorbent Assay (ELISA) 
 The continuous efforts to improve serological procedural systems have resulted 
in the wide acceptance of ELISA. The indirect ELISA, for example, detects all 
isotypes of antibodies, but lacks the efficiency for differentiation between post-
vaccine antibodies from those induced by natural infections or cross-reacting 
bacterial antigens (Nielsen et al., 1996a; 1996b); thus, it is well suited for 
serological surveys where vaccination is not practiced (Samartino et al., 1999). 
The antigen used can be the complete bacterial cell or semi to highly purified 
smooth lipopolysacharide (S-LPS). However, less purified antigens have the 
advantage of reduced micelle formation and are more stable than the highly 
purified forms. In addition, the selection of anti IgG1 heavy and light chain 
reagents e.g. mouse anti-bovine IgG1, increase specificity and reduce false 
positive reactions (Nielsen & Duncan, 1990). 
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Competitive ELISA (C-ELISA) using monoclonal antibodies was pioneered by 
Quinn et al. (1984), and is based on competition between two antibody 
populations for a limited number of antigenic epitopes. Conjugated monoclonal 
antibodies to a single epitope, with highly purified antigens, guarantee the 
specificity of the test. If B. abortus antibodies are present in the test sample, they 
compete by displacing the conjugates correlated with the amount of specific 
antibody present in the sample. The test has a number of advantages over indirect 
ELISA, as it is a multi-species test requiring fewer steps and without needing of 
anti-species conjugates: it is capable of differentiating between vaccinated and 
field infected animals (Schelling et al., 2003). 
Polymerase Chain Reaction (PCR) 
 Non-culture detection methods, including fluorescent antibody test and 
immunoperoxidase staining, in addition to non-isotopic DNA hybridisation, offer 
rapid accurate detection in the absence of good cultures (Hopper et al., 1989). 
Current PCR-based procedures provide a reliable aid for the detection of 
pathogens in tissues (Fekete et al., 1992). However, for the accurate diagnosis 
extreme caution should be practiced, as none of the above-mentioned tests is 
suitable in all circumstances. For more information about PCR, see the Bovine 
Viral Diarrhoea Virus section below. 
 
Prevention and control  
 The successful elimination of brucellosis in some countries is a consequence of 
well-conducted comprehensive control and eradication programmes, with 
screening and confirmatory tests and prompt removal of reactors, in addition to 
bio security and vaccination (Reviewed by Songer & Post, 2005).  
 Vaccination enhances the resistance of the animals in infected herds, and 
reduced doses of B. abortus strain 19 live vaccine is given to adults with 
systematic administration to heifers 4-12 months old. Other vaccines based on 
strains RB51 or 45/20 provides excellent immunity and  recommended for the 
control of brucellosis in cattle (Chukwu, 1987; Stevens et al., 1995),  and the Rev-
1 live vaccine secures lifelong immunity against B. melitensis in small ruminants 
(Blasco, 1997). 
 
 The control of brucellosis in camels in the UAE is hampered by lack of reliable 
demographic information, uncontrolled movement of camels across the borders to 
the Gulf States and the import of animals from other countries for racing. In this 
context, the camel population in Al Ain region has been estimated at around a 
hundred thousand heads (Moustafa et al., 1998). An increased understanding of 
the pathogenesis, host immunity interactions and genetic bases of persistence is 
the pivot of current research. Accordingly, choices of sub-unit vaccines or DNA 
immunization have shown efficacy and hold promise for a generation of highly 
effective genetically engineered vaccines (Kurar & Splitter, 1997). The optimised 
status of control for eradication is a persistent scientific challenge that should 
receive increased international financial and political support. 
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2. Bovine Viral Diarrhoea Virus (BVDV) 
Epidemiology and pathogenesis 
 Bovine Viral Diarrhoea Virus (BVDV) is the prototypic representative of the 
genus pestivirus, family Flaviviridae, that includes classic swine fever and sheep 
border disease viruses. BVDV is a ubiquitous primary pathogen of cattle and 50-
90% of cattle in the world have been exposed. The virion is an enveloped 40-50 
nm particle, with a single stranded positive-sense, non-polyadenylated RNA 
genome, and is approximately 12.3 -12.5 kb in length. The genome has one large 
open reading frame (ORF) located between the 5 and 3 non-coding translated 
regions, encoding a single 4000 amino acid hypothetical polyprotein. The 
biogenesis of the ultimate structural and non-structural viral proteins occurs 
through proteolytic processing of the precursor polyprotein utilizing various 
cellular- and virus-originated peptidases (Collett et al., 1991; Houe et al., 1995; 
Paton et al., 1995).  
 According to the detectable differences in the genome, two BVDV genotypes (I 
and II) have been described based on differences in the 5’ non-coding region 
(5’NCR) nucleotides sequence (Pellerin et al., 1994). The variations in the 5’NCR, 
the non-structural protein, and envelope glycoprotein E2 regions further 
characterised BVDV into sub-genotypes and updating of the pathogen phylogram 
(Collett, 1996). Moreover, the differentiation of BVDV genotypes, sub-genotypes 
and other pestiviruses is performed serologically either by differential virus 
neutralization test, or with monoclonal antibodies against E2, as well as genomic 
typing (Wensvoort et al.,, 1989; Ridpath, et al., 1994a; Letellier et al., 1999; 
Fulton et al., 2003). BVDV-1 has at least five subspecies (1a-1e), predominantly 
originating from cattle, and occurs worldwide, whereas, BVDV-2 appears to be 
mainly restricted to North America, where it has been implicated in outbreaks of 
severe thrombocytopenic and hemorrhagic form of the disease (Rebhun et al., 
1989; Van Rijn et al., 1997; Brownlie et al., 2000). 
 Two distinctly differentiated BVDV biotypes, a cytopathic strain (cp), and a 
non-cytopathic strain (ncp) were characterized in culture cells (Meyers & Theil 
1996). The ncp strain is regarded as the standard BVDV and  spreads more 
extensively throughout host tissues than the homologous cp strains do and 
includes both virus 1 and 2 genotypes. Only the ncp biotype can trespass the 
placental barrier in pregnant seronegative females and establish a persistent 
infection (PI) in foetuses. If PI offsprings are superinfected by exogenous, 
genetically homologous cp strains, they may develop the fatal Mucosal Disease 
(MD); whereas, synergistic heterologous strains generate a chronic atypical form 
of the disease (Westenbrink et al., 1989; Gronstol et al., 1988). MD is a dramatic 
indication of the presence of BVDV in a herd and either of the two disease forms, 
the sudden or the late onset, results in poor survivability due to severe and profuse 
diarrhoea and progressive debilitation (Brownlie & Clark, 1993; Moening & 
Liess, 1995). Cp strains are postulated to generate a de novo form by mutation of 
ncp counterparts in PI animals (Moening & Plagemann, 1992; Meyers & Thiel, 
1996). 
 The BVDV associated infections comprise five forms with variable degrees of 
severity, presented clinically as: diarrhoea, respiratory signs, thrombocytopenia, 
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and immunosuppression (Grooms et al., 2002). However, unapparent infections 
are usual and an acute infection is generally subclinical and benign in most 
immuno-competent sero-negative animals. Profuse diarrhoea, oro-mucasal lesions, 
oculo-nasal discharges, agalactia and reproductive failure are reported from severe 
acute disease. In addition, clinical or pathological diffuse gastrointestinal 
ulceration, lymphoid necrosis, lameness and various congenital malformations, 
have been described. The hemorrhagic syndrome with thrombocytopenia may 
present as bloody diarrhoea, epistaxis, and oral and conjunctival haemorrhages 
(Corapi et al., 1990; Liebler-Tenorio et al., 2002). The association of BVDV with 
calf respiratory disease is a consequence to the immunosuppressive activity of the 
virus that potentiates the host’s susceptibility to opportunistic co-infecting 
respiratory and enteric pathogens. Accordingly, pneumonia, enteritis and an 
increased incidence of udder infections are occasionally reported (Richer et al., 
1988; Lindberg & Emanuelson, 1997). 
 The foetopathogenic outcomes of diaplacental infections are determined by the 
pregnancy length at onset (For review see Sager & Ridpath, 2005). Early 
incidence in the first trimester results in embryonic death; whereas, incidence at 
mid-gestation, and before competent immunity develops, results in abortion or 
pre-natal dysmorphogensis. The teratogenic effect of the virus retards ocular and 
nervous tissue development, resulting in several congenital anomalies, collectively 
known as oculo-cerebellar syndrome (Bielefeldt-Ohmann, 1984). Foetuses 
infected during early pregnancy are borne immunotolerant, persistently viraemic 
and are candidates for developing fatal MD (Moening  & Liess, 1995). 
 The main transmitters of BVDV are PI animals and they have an enormous 
impact on the epidemiology of the disease, as susceptible herd-mates contract the 
pathogen when exposed to their contaminated shedding (Duffel & Harkness, 
1985). Iatrogenic transmission through contaminated needles, vaccines, semen, 
transferred embryos, and negligence of precautionary hygiene measures and 
practices, enhance the probability of virus introduction (Gunn, 1993; Barkema et 
al., 2001). 
 
 The prevalence of BVDV in NWC and OWC has been described in several 
scientific works and the virus has been isolated from infected camels (see Table 2. 
BVDV is considered as the cause of death in both NWC and OWC and has been 
associated with cases of diarrhoea, stillbirth, intrauterine death, neonatal 
mortalities, and abortion. The virus also causes unthriftiness, weight loss and MD-
like symptoms: some studies estimate the loss of newborn camel calves due to 
BVDV infections to reach 50% (Hegazy & Fahmy, 1997). Furthermore, 
congenital deformities, neonatal respiratory distress, and acute hemorrhagic 
gastroenteritis have also been reported in camelids (Mattson, 1994; Hegazy et al., 
1998; Belknap et al., 2000; Wentz et al., 2003; Abd-Elhakim, 2004). 
 
Diagnosis  
 Diagnosis based on clinical features is difficult and unreliable owing to the 
marked clinical variations of BVDV infections (Baker, 1995). Therefore, 
laboratory diagnosis of BVDV is necessary to confirm the presence of the virus, 
and is successfully accomplished by direct detection of virus or viral components, 
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or serology. For an accurate interpretation of the results, clinical samples must be 
accompanied by herd history and vaccination status (Reviewed by Nettleton & 
Entrican, 1995). 
Virus isolation (VI) and antigen detection 
 For viral isolation of cp strains, primary bovine cells are used. Increased 
sensitivity is best achieved by proper volume of inoculum and incubation period, 
and quality assured pestivirus free and species-specific susceptible cells: viraemia 
encountered in a few samples collected three weeks apart indicates PI (Brownlie, 
et al.,2000). Non-cytophathogenic strains are identified by immunofluorescence 
(IF), immunoperoxidase staining (IPX) and antigen-captured ELISA. Both , the 
cytopathogenic and the non-cytopathogenic biotype, have been cultivated from 
spleen and blood of MD affected animals and viral antigens have been detected by 
IF or IHC in biopsies or section of frozen tissues (Dubovi, 1990; Sandvik, 1999). 
 
Polymerase Chain Reaction (PCR) 
 Reverse transcriptase (RT)-PCR, the current standard method for the detection 
of viral RNA, is more sensitive and efficient than dot blot hybridisation and virus 
isolation (Brock, 1991), which is affected by absence of live virus or presence of 
higher levels of antibodies in the material submitted (Zimmer et al., 2004).  The 5-
NCR of the genome is the target for the selection of primers (Ridpath, 1993). The 
nested PCR is 100-fold more sensitive than the single step assay and detects the 
smallest concentrations of virus RNA in sera (Gruber et al., 1994; Elvander et al., 
1998). In dairy farming, the test is used to detect PI animals and is performed on 
bulk tank milk, but is not valid for non- lactating animals (Graham et al., 2001; 
Sandvik, 1999). The assay is validated by co-amplification of standard mimics, 
minimizing manipulation of samples with real time PCR, or single tube 
fluorogenic assays to enhance sensitivity and elimination of false results (Ballagi-
Pordany & Belak, 1996; Bhudevi & Weinstock 2001). 
 
Virus Neutralization (VN) test  
 The virus neutralization test has been considered as the “gold standard” test for 
the detection of antibodies against BVDV. However, it is expensive, laborious and 
impractical for large scale monitoring. The use of cp strains permits accurate 
identification of neutralizing antibodies, whereas immunoperoxidase staining 
(IPX) of infected cells is used for detection of virus infectivity inhibition of ncp 
strains (Fulton et al., 1997). However, the absence of neutralizing antibodies in PI 
animals and interference with colostral immunoglobulins limit the diagnostic 
performance. Due to the antigenic heterogeneity of BVDV, the selected strain 
should be of reliable capacity for detecting the majority of infected animals within 
a particular area. The biotype can be accurately identified because of the 
difference between titres in infected animals and titres induced by vaccination 
(Jones et al., 2001). 
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The Enzyme Link Immunosorbent Assay (ELISA) 
 ELISA (indirect and blocking) for either milk or serum is a rapid alternative to 
the VN test. The blocking ELISA is based on the competition between antibodies 
and a peroxidase coupled anti-p80 monoclonal antibody. The percentage of 
inhibition for each sample is calculated relative to negative controls. As the test 
has 97% sensitivity and specificity compared to VN tests (Beaudeau et al., 2001), 
the serological status of dairy herds can be reliably determined with indirect 
ELISA on bulk milk. The antigen-captured ELISA, using monoclonal antibodies 
against the conserved p125/p 80, is a highly specific method, and correlates well 
with conventional VI methods, however, the presence of colostral antibodies may 
interfere with the identification of PI animals by both methods (Fenton, et al., 
1991; Shanon et al., 1992; Katz & Hanson, 1987). From serological surveys in 
some tropical countries, antibodies to BVDV in dromedary camels give different 
prevalence rates, indicating the importance of the disease in this species (Table 2). 
 
Control and prevention 
 The detection and elimination of PI animals and stringent biosecurity for 
preventing the introduction of the virus are key elements for designing efficient 
large-scale controls with or without vaccination (Bitsch & Ronsholt, 1995; 
Graham et al., 2001). Testing bulk milk or a small number of animals, aged 6-18 
months, will enable accurate prediction of PI animals in whole-herd screening 
protocols (Houe, et al., 1995). In utero detection of PI foetus in newly introduced 
pregnant heifers reduces the establishment of PI family lines by blocking an 
important intra-herd vertical route of spreading (Lindberg et al., 2001). After the 
removal of PI animals, maintenance of BVDV free herds is essential, as is 
mandatory testing before the introduction of  new animals. Vaccination is an 
important preventive measure. The advantages and disadvantages of live and 
killed vaccines have been reviewed (van Oirschot et al.,1999). An alternative to 
vaccination is natural exposure, PI animals are used as bio-immunisers to protect 
young animals, which simultaneously confers protection to the older co-resident 
animals; however, risky repercussions cannot be ruled out (Pasman et al., 1994). 
 
 The absence of BVDV antibodies in bulk milk or the absence of sero-conversion 
in spot-tests are considered sufficient criteria to certify a herd as BVDV free, and 
vice versa, and is a practice employed in eradication programmes (without 
vaccination) implemented in Scandinavian countries. Repeated multiple testing of 
BVDV-free herds, and methods that support self clearances in infected herds are 
essential complementary practices for the control of the disease (Bitsch & 
Ronsholt 1995; Lindberg & Alenius, 1999). Despite decades of vaccination with 
different types of vaccines, the optimal control and elimination of the disease is far 
from complete in many endemic regions, which is due to the diverse antigenicity 
of the virus, and complex pathogenesis. 
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3. Bovine Herpes virus-1 (BHV-1) 
 Epidemiology and pathogenesis 
 Bovine Herpes Virus type 1 (BHV-1) belongs to the Herpesviridae family, 
subfamily alpha herpesvirinae, genus varicella virus. BHV-1 is the aetiology of a 
number of clinical diseases, including infectious bovine rhinotracheitis, (IBR), 
infectious pustular vulvovaginitis (IPV) and balanoposthitis (IBP), as well as a 
systemic generalized form accompanied by encephalitis (For review see Straub, 
2001). 
 The presence of BHV-1 subtypes may explain the dissimilar pathological and 
epidemiological features of the disease. Through genomic analysis, Metzler et al., 
1985, described three distinct subtypes: 1, 2a, and 2b. However, Rozimann et al., 
1992, reported a classification reflecting the subtypes based on tissue tropism: 
BHV-1.1 as a respiratory subtype; BHV.1.2 as a genital subtype, which were 
further divided by Miller et al., 1995 into a and b groups; and BHV-1.3 (renamed 
BHV-5) as a neurovirulent encephalitic subtype. Cattle are the principal hosts; 
however, the virus has been reported in swine, goats, camels and wild ruminants, 
which are considered as reservoirs (Rimstad, et al., 1992). 
 The epidemiological data and sero-surveys in various countries indicate a 
worldwide distribution. Prevalence rate in developed countries fluctuates 
depending on immunization practices and exposure of naïve herds to the infectious 
virus (Durham et al., 1991). The latency of the virus in the sciatic, trigeminal 
ganglia, or tonsils following primary infections, with corresponding recrudescence 
and continuous or intermittent release, explains the virus-complicated 
epidemiology. Stress or administration of corticosteroids reactivates latent 
infections (Thiry et al., 1987; Winkler et al., 2000). Virus transmission is through 
contact, or indirectly through contaminated feed and drinking water. Therefore, 
cattle in feedlots have higher morbidity (20%-30% up to 100%), as husbandry 
systems potentiate virus emergence, transmission and maintenance, than the 3-8% 
in dairy heifers affected by IPV (Radostits & Arundel, 2000). In uncomplicated 
respiratory form, the average mortality is 10% and in the reproductive tract form, 
it is negligible. BHV-1 related-diseases complex accounts for huge economic 
losses due to reduced milk production and dropped feed efficiency, IPV/IBP-
induced infertility, abortion, neonatal mortality, and reduced conception 
(Kaashoek, 1996). 
 BHV-1 causes both clinical and sub-clinical infections. The clinical disease has 
two major pictures: a respiratory form of varying severity affecting animals 6-
months to 2-years-old, and a venereal form affecting adult males and females 
genital organs (van Oirschot et al., 1993; Hage et al., 1996). 
 
The respiratory (IBR) form 
 This form is typical rhinotracheitis and is usually acquired through aerosols or 
droplets. It involves the entire respiratory tract with increased severity in younger 
calves. Fever and depression progress to rhinitis, laryngitis, and tracheitis with 
dyspnoea, deep coughing, and hyperexcitability. Moreover, nasal mucosa is 
extensively hyperaemic and ulcerated, with necrotic foci in the nostrils and 
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muzzle. Profuse mucopurulent bloodstained discharges are usually seen. 
Occasionally, conjunctivitis with corneal involvement and abundant lacrimation 
may be the sole clinical abnormality. Abortion or stillbirth of extremely autolized 
foetus during the last trimester is common in non-immunized pregnant cows. 
Infected animals exhibit elevated susceptibility to fatal broncho-pneumonia, or 
endometritis in the genital form, subsequent to secondary bacterial infections 
(Babiuk et al., 1995). IBR in newborn calves is a fatal generalized systemic 
disease, characterized by gastroenteritis with diarrhoea, and oculitis. Virus 
neurotropism leads to meningo-encephalitis with in-coordination and convulsions, 
which represents another variety of BHV-1 infection. 
 
The genital (IPV) form 
 Natural service or infected semen in artificial insemination centres and 
contaminated milking machines are implicated in the IPV transmission most 
commonly observed in diary cows. Swollen and exudating labia vulvae, necrotic 
ulcers and formation of pustules in the vestibular mucosa, with painful and 
frequent urination, is described. In males, continuous discharge, and persistent 
lesions in the penis are observed in bulls affected by IBR. There is rare evidence 
of simultaneous onset of both forms in an individual animal, or a particular herd, 
but generally, one type is predominant (Murphy et al., 1999). 
 The pathogenesis is mostly encountered at the mucus membranes of the upper 
respiratory tract or of the vagina and prepuce. Several envelope glycoprotein and 
cellular receptors mediate a viral multistep entry process into the cells 
(Mettenlieter, 1994). Rapid initial replication occurs and produces local cytolysis; 
the resultant cell destruction is responsible for the acute symptoms and the 
leukocyte associated primary viraemia that lead to virus dissemination to different 
host tissues (Engels & Ackermann, 1996). 
 
 Evidence of BHV-1 infection in OWC is scarce but a higher prevalence has 
been reported in NWC, particularly in llamas and alpacas, and in association with 
bronchopneumonia, encephalitis, and progressive cough. A higher prevalence of 
the disease has been reported when grazing pastures are shared with other 
ruminants (Wernery & Kaaden, 1995; Williams et al., 1991; Mattson, 1994; 
Rivera et al., 1987; Picton, 1993). 
 
Diagnosis 
Virus isolation 
 The clinically observed signs of the reproductive form and conjunctival lesions 
provide a relatively reliable basis for tentative diagnosis. However, several 
laboratory methods, including electron microscopy, virus isolation, 
immunofluorescens (IF), immunoperoxidase (IPX) staining, and antigen ELISA, 
are essential for the identification and confirmation of the different forms of the 
disease. In the early acute febrile stages, the virus is isolated from samples of 
nasal, ocular, and genital swabs. The cytophathic effect (CPE), in cultures of 
various cell types of bovine or swine origin, indicates the presence of the virus. In 
addition, in situ demonstration of viral antigens by IF or IPX assays is usually 
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practiced and is applicable for post-mortem collected tissues (Kaashoek et al., 
1994). 
 
Virus Neutralization (VN) test  
 The Virus Neutralization (VN) test is the utmost confirmative test and is 
applicable for bovine kidney, lung, tracheal, and other cell lines of bovine origin. 
The sensitivity of the test can be maximized by a prolonged virus/serum 
incubation period (Bitsch, 1978). 
 
ELISA 
 Different ELISA are used for antibody detection in individual or pooled blood 
sera, as well as in bulk milk, and is useful for determining herd status. The optimal 
accuracy of the tests means they are a reliable alternative to the VN test in areas of 
high prevalence (Pritchard, 2001). Recent infections can be successfully diagnosed 
by an IgM-ELISA, where immunoglobulin IgM predominate the primary immune 
response. Furthermore, indirect ELISA has 100% sensitivity when undiluted test 
serum samples are used. Therefore, the test can detect low levels of specific 
antibodies  undetected by other conventional assays (Lemaire et al., 1995). The 
commercially available blocking ELISA kits with monoclonal antibodies can 
discriminate immunized from naturally infected cattle in regions where marker 
vaccines are used. (Perrin et a1., 1993; van Oirschot et al., 1997). 
 
PCR  
 PCR is used for viral DNA detection in semen and is a valuable complementary 
technique for classic viral detection methods (Vilcek et al., 1994; van 
Engelenburge et al., 1995). 
 
Control and prevention 
 Unpredictable virus occurrence, latency and sub-clinical shedding are major 
obstacles jeopardizing any control programme, although occasionally, natural 
exposure to the virus confers solid immunity. Eradication schemes without 
vaccination have been successfully implemented in Scandinavian countries and 
Switzerland (for review see Radostits and Arundel, 2000). The strategy adopted 
was based on prompt notification and prohibition of vaccination to unmask natural 
or latent infections, in combination with annual testing and trade restrictions 
(Ackermann et al., 1990; De Wit et al., 1998). The feasibility of such programmes 
is doubtful in countries with high prevalence rate, where restriction on animal 
movement and culling of infected animals face practical difficulties due to the 
extensive nature of animal production. Therefore, in many countries vaccination 
has been used (Paton et al., 1998). The currently used vaccines include 
conventional inactivated or modified life vaccines, in addition to subunits and 
marker vaccines, which allow discrimination of animals infected with wild-type 
pathogens from the vaccinates. Although all have proved beneficial in certain 
conditions, several vaccination disadvantages are still reported  (Nettleton et al., 
1984). 
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Introduction to the research report 
 Camels are essential sources of human food and constitute important supplies of 
milk, meat and wool, in addition to their use in the traditional popular racing sport, 
which is important to the rapidly growing tourism industry in Arab countries. In 
recent decades, the numbers of Camels has steadily increased due to the 
introduction of modern husbandry methods and efficient veterinary services. The 
scarcity of scientific publications on infectious diseases in camels has urged 
scientists to focus more attention on research and expand knowledge of this 
species. Camels are frequently infected with Brucella abortus because of their 
contact with other ruminants and consumption of unpasteurised bovine milk. In 
addition, the local habit to drinking raw camel’s milk is of major public health 
concern as camels have varying degrees of susceptibility to BVDV and Bovine 
Herpes Virus type 1 (BHV-1), and their role in the epidemiology of these diseases 
requires more attention. 
 
 This work attempted to study the occurrence of the three important pathogens in 
serum samples from camels in the Al-Ain region, United Arab Emirates. 
Although, both viral pathogens do not directly threaten human health, together 
with B. abortus they are serious immunosuppressive pathogens and cause 
economic impact to animal production and international trade. 
 
Aims of the study 
 The general aim of this work was to use ELISA for determining the presence of 
antibodies against B. abortus, BVDV, and BHV-1, which were suspected of 
affecting the reproductive system of camels in the Al-Ain region of the United 
Arab Emirates. 
 
 The specific aims of the research reported in this thesis, were: 
 
• To introduce ELISA for the detection of B. abortus, BVDV, and 
BHV-1 in camelids, and to identify their role in transmission and 
spread in the camel population.  
• To assess the reliability of both competitive and blocking ELISAs 
as diagnostic tools for use in more comprehensive studies  
• To study the occurrence of the three diseases in groups of animals 
with different management systems. This will assist the 
assessment of the efficacy of control and eradication programmes 
already initiated by the local authorities and provide 
recommendations for strengthening future control of camel 
diseases in the region 
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Research report 
A survey of antibodies to Brucella abortus, Bovine Viral 
Diarrhoea Virus (BVDV) and Bovine Herpes Virus-1 (BHV-1) in 
camels from the Al-Ain region in the United Arab Emirates 
 
Abstract 
 Serum samples from 812 camels of both sexes and different ages were randomly 
collected from the local abattoir and livestock market and from10 private holdings in the Al 
Ain region of the United Arab Emirates. A commercial competitive ELISA, based on a 
monoclonal antibody, determined the presence of Brucella abortus antibodies, and a 
commercial blocking ELISA was used for the detection of antibodies to BVDV and BVH-1. 
Suspected or non-specific positive results were retested by confirmatory tests such as 
Complement Fixation or Virus Neutralization tests as required. The results indicated that no 
sera from the 812 camels were positive for any of the three pathogens. This highlighted the 
need for further comprehensive studies and a reconsideration of the sampling on a defined 
epidemiological basis, and with cut-off values for commercial ELISA kits originally 
designed for other species, and which are used for testing camel sera. A performance 
evaluation of commercial ELISA kits used on camel sera should be a priority for future 
epidemiological studies. 
 
Introduction 
 Single humped camels, Camelus dromedarius, together with the two humped 
camels Camelus bactrianus, inhabit wide areas throughout the world, including 
the Arab Gulf States, and have an important impact on people’s life as essential 
sources of human food and entertainment. Camels have a unique adaptation to 
harsh environmental conditions such as those existing in Arabian Gulf States. The 
adoption of modern husbandry and management methods and availability of 
efficient veterinary services has steadily increased the number of camels as an 
alternative source of milk and meat, in addition to the widely popular racing sport. 
The accurate determination of the incidence of brucellosis in the UAE, including 
the Al-Ain region, faces several problems in part due to the absence of reliable 
demographic information on camel population and the uncontrolled movement 
and import of camels from other countries. As the camel population is roughly 
estimated as a hundred thousand heads, the animal health authorities are forced to 
give more support for determining the health status of camels in the region 
(Moustafa et al., 1998). 
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Brucella abortus (B. abortus)  
 Brucella abortus was first reported in camels in 1931 (Solonitsyn, 1949). 
Camels are considered as having relatively high susceptibility to B. abortus 
infection, especially when they are in contact with infected large or small 
ruminants (Hashim et al., 1987; Radwan et al., 1995). The incidence and 
prevalence of the disease has been clearly related to the type of breeding and 
husbandry practices (Richard, 1980; Abbas & Agab 2002). A low prevalence 
occurs in nomadic or extensively kept pastoralist camels, whereas, a higher 
prevalence is found in intensively or semi-intensively reared animals. The duration 
of inter-calving intervals, which is longer in nomadic camels, appears an important 
factor. Similar findings are reported from Saudi Arabia and Sudan indicating the 
same difference in incidence pattern (Abu Damir et al., 1984; Wernery & Wernery 
1990; Radwan et al., 1992; FAO, 2003). 
 
 Different biotypes of B. abortus and B. melitensis are involved in camel 
brucellosis (Higgins, 1986; FAO 1986; Radwan et al., 1991; Wernery & Kaaden, 
1995) and different prevalence rates are reported in several countries (FAO 1986). 
The prevalence of brucellosis in camels in various countries is presented in Table 
1. Abortion is the main clinical finding, but placental retention has not been 
described (Radwan et al., 1995; Fowler, 1998). Pathological changes are 
associated with the disease, including lesions in ovario-bursal, hydrobursitis and 
granulomatous endometritis and endometrial fibrosis (Agab, 1993; Nada & 
Ahmed, 1993). 
 
 Most data on B. abortus infection in camels are based on serological surveys; 
although, isolation from blood, milk, lymphoid tissues, and diagnosis through 
immunohistochemical methods has been described (Abu Damir et al., 1989; 
Gameel et al., 1993). Besides the conventional tests, such as slide agglutination 
(SAT), buffered-plate agglutination  (BPAT), buffered-acidified plate antigen 
(BAPAT) and card or Rose Bengal tests (RBT), the Complement Fixation Test 
(CFT) is considered as the most sensitive diagnostic test for brucellosis in camels. 
Moreover, it has often been considered as a confirmatory test for brucellosis, with 
four times higher sensitivity than the agglutination test (Shumilov, 1974; Nielsen, 
et al., 1984; Alton, et al., 1988; Wright & Nielsen, 1990). Indirect and competitive 
ELISA have successfully detected antibodies to B. abortus in milk and sera 
(Starten et al, 1997). 
 
 The C-ELISA used in the present study, is a multi-species assay for the 
detection of antibodies to B. abortus or B. melitensis in serum. This test naturally 
discriminates infected animals from those vaccinated with strain 19 and animals 
infected with serologically cross-reacting bacteria such as Yersinia enterocolitica 
and different serotypes of Salmonella and E.coli. The performance of C-ELISA is 
comparable to the CFT test, therefore, it can reasonably be used as a sole test for 
the diagnosis of brucellosis (Nielsen et al., 1995). As data on the prevalence of 
camel brucellosis in most countries is limited and not updated information, there 
are many gaps in the knowledge of the epidemiology, pathogenesis and clinical 
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patterns of the disease, which therefore merit further investigation (Radwan et al., 
1992). 
Bovine Virus Diarrhoea Virus (BVDV)  
 BVDV is an important pathogen causing significant economic losses primarily 
due to reproductive failure, infertility and neonatal mortality. The virion is an 
enveloped, 40-50 nm virus member of the family Flaviviridae, genus pestivirus. 
The genome is a single-stranded positive-sense RNA molecule, approximately 
12.5 kb in size. The virus has two genotypes, BVDV-1, with a worldwide 
distribution, and BVDV-2 that appears geographically restricted to the U.S. and 
Canada. The virus has two biotypes: cytopathogenic “cp”, and non-cytopathogenic 
“ncp” types, which are differentiated according to the presence or absence of 
microscopic pathological changes in cell cultures (Reviewed by: Ridpath, 2005). 
 Tthe involvement of type -1 in severe outbreaks of the disease has been 
reported. In addition, the virus is an immunosuppressive agent with an affinity for 
the lympho-reticular system, which enhances the host susceptibility to other 
pathogens i.e. Herpesviruses (Potgieter et al., 1984; Bolin et al., 1985; Peterhans 
et al., 2003). The prevalence of BVDV infection in OWC and NWC has been 
described and the virus has been isolated from infected camels (Evermann et al., 
1993; Mattson, 1994; Hegazy et al., 1998). 
 In some tropical countries, antibodies against BVDV in camels reveals different 
rates of prevalence, as highlighted in Table 2, which indicates the importance of 
the disease in camelids. The cp biotype has been isolated from lymphoid tissues, 
spleen, brain and kidney in bovine kidney cells, and detected by immuno-
histochemical methods in different organs (Wernery & Kaaden 1995; Belknap et 
al., 2000).  
 
 BVDV is considered as the cause of death in both OWC and NWC and is 
associated with cases of diarrhoea, stillbirth, intrauterine death, neonatal 
mortalities, and abortion. The virus also causes unthriftness, weight loss and MD-
like symptoms and is responsible for approximately 50% loss of newborn camels 
in Egypt (Hegazy et al., 1995). Furthermore, congenital deformities and poor 
viability, neonatal respiratory distress, acute haemorrhagic gastroenteritis is also 
reported (Belknap et al., 2000; Hegazy & Fahmy 1997; Hegazy et al., 1998). 
 
Bovine Herpes Virus-1 (BHV-1) 
 Bovine Herpes Virus, BHV-1, is the causative agent of infectious bovine rhino 
tracheitis  (IBR), abortion, and, in rare cases, encephalitis in cattle and IPV/IBP in 
bulls. The virus comprises respiratory, genital, and encephalitic subtypes known as 
BHV-1.1, 1.2 and 1.3, which has been renamed BHV-5 (Roziman et al., 1992). 
IBR acts also as an immunosuppressive agent predisposing the host to a several 
secondary bacterial invasions (Reviewed by Straub, 2001) and is most often 
characterised by respiratory syndromes manifested by coughing, rhinitis, fever, 
and broncho-pulmonary complications, and, has a propensity to remain latent after 
the primary infection, and might be later provoked after a viral reactivating event. 
The high losses due to this viral disease justify the meticulous monitoring of 
susceptible herds for exposure to the virus. 
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 Evidence of BHV-1 occurrence in OWC is scarce. However, Schwyzer & 
Ackermann, 1996 and Bildfell et al., 1996, describe encephalitis and blindness in 
camels caused by Equine herpesvirus-1 EHV-1, which has a close genetic relation 
to BHV-1. Higher incidences of BHV-1 associated diseases are reported in NWC 
than in OWC counter parts: bronchopneumonia, encephalitis, and progressive 
cough are evident in llamas and alpacas (Rivera, 1987; Rebhunn et al., 1988; 
Williams et al., 1991; Picton, 1993; Mattson, 1994). Higher prevalence has been 
recorded when grazing pastures are shared with other ruminants. The lack of 
positive results to BHV-1 in experimentally infected OWC is perhaps attributed to 
the difficulties in detecting natural or experimentally–induced humoral responses 
to BHV-1 in some laboratories. However, a prevalence of 13.5% is reported in 
samples of 171 dromedaries in Egypt (Moussa et al., 1990) and antibody titres 
(1:5) are reported in 5.8% of dromedary samples screened in Tunisia (Wernery & 
Kaaden, 1995). 
 
 
Materials and methods  
Animals and serum samples 
 The study comprised 812 camels of nomadic and intensively reared animals, 
which represented different husbandry and management systems. The sampling 
frame included 392 males and 14 females from the central abattoir, 108 males and 
102 females from the camel markets and 111 males and 85 females from 10 
privately owned farms. The age of the animals ranged from 1-12 years in both 
sexes. The geographical origins, and sex, were recorded. All animals were 
clinically normal at the time of sampling, May-July 2002. Table 3 summarizes the 
origin, sex, and total numbers of sampled animals. 
 
Sampling procedures 
 Plain vacutainer tubes without anticoagulant were used to take 5-7 ml of blood 
from the jugular vein. Serum was separated from the coagulated blood by 
centrifugation at 1000x g for 10 minutes. The sera were inactivated by heating in a 
water bath at 56ºC for 2-3 hours and stored at -20 ºC until use. 
 
Serological tests 
Competitive ELISA for detection of antibodies against B. abortus 
 A commercial Brucella abortus C-ELISA supplied by SVANOVA Biotech, 
Uppsala–Sweden was used. The kit procedure was based on a solid phase 
competitive ELISA, where samples were exposed to Brucella abortus smooth 
lipopolysaccaride (S-LPS) coated wells on microtitre plates, together with a mouse 
monoclonal antibody (mAB) specific for an epitope on the o-polysaccharide 
portion of the S-LPS antigen. After incubation, the microplate was washed and 
goat anti-mouse IgG antibody conjugated with horseradish peroxidase was added. 
The latter binds to any mABs bound to the S-LPS on the plate. Colour 
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development is due to the conversion of the substrate by the conjugate. The mean 
optical density (OD) values at 450 nm of the controls and the tested samples were 
used to calculate the percent inhibition PI with the formula: PI=100- mean OD 
samples or control times 100/ mean OD of conjugate controls CC. The remaining 
steps of the test followed the manufacturer’s instructions (SVANOVA Brucella -
Ab C-ELISA manual), including the interpretation of the results.  
 
Blocking ELISA for detection of antibodies to BVDV- BHV-1 (IBR) 
 All sera were examined for the presence of BVDV and BHV-1 (IBR) antibodies 
with commercial blocking-ELISA (B-ELISA) kits manufactured by Institute 
Pourquier, France (http://www.institut-pourquier.fr.). The principle of the test was 
based on the P80 protein of the virus coated on wells of a microplate by means of 
a specific monoclonal antibody “WB103”. If antibodies against BVDV were 
present in the sample, they formed a bovine (or camel) antibody-P80 complex, 
through which the P80 became “masked”. After washing, a monoclonal antibody 
“WB112” (directed to another epitope of P80) coupled to peroxidase was 
incubated in the wells. In the presence of antibodies in the sample, the P80 protein 
sites were “masked” and the conjugate could not bind to the corresponding 
epitope, but the conjugate could bind to the P80. After further washing, the 
substrate was added to the conjugate, forming a blue compound, which became 
yellow after the blocking step if the sample was negative.  
 The general principle of the B-ELISA for the detection of antibodies against 
BHV-1 is exactly similar to the procedure followed for the detection of antibodies 
against BVDV. Here, the wells of microplates were precoated with an ultra 
purified BHV-1 lysate. Any antibody specific to the glycoprotein gB of the virus 
present in the sample formed a gB-antibody immune complex, which effectively 
masked the gB sites.  
In order to consider the BVDV ELISA test as valid, the OD of the negative control 
(NC) is at least 0.800 and the PI of the positive control (PC) <20%.For IBR ELISA a 
minimum OD of 0.800 for NC and PI<30% is required for a valid test. PI for both tests was 
calculated by the equation: OD450 nm of analysed serum/mean OD 450 nm of the NC x 
100. 
 The details of both tests followed the manufacturer’s instructions and the 
validation criteria and interpretation of results is summarised in Table 4. 
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Results 
Brucella abortus  
Sixty-six out of 812 samples revealed a percent inhibition ranging from 20-25. 
The same results were found in two repetitive tests. The distribution of the 
samples with the above mentioned percent inhibition was 18 samples from the 
abattoir, 16 from the market and 32 from the private farms. As range of the 
percent inhibition values (20-25) was not clear-cut (Table 4), it might be an 
indication of the presence of low levels of specific antibodies. The 66 samples 
were re-tested for confirmation with Complement Fixation Test: none of the 
samples was f positive with CFT. The test was performed following the protocols 
of the Department of Bacteriology Swedish National Veterinary Institute (SVA) 
Uppsala-Sweden. 
 
BVDV, BHV-1 tests 
 Three out of 210 samples obtained from the camel market revealed OD values 
of 0.220, 0.645 and 1.046 with corresponding calculated percent inhibition values 
of 13, 38 and 55. These samples were suspected as being positive for BVDV. A 
further two out of 210 samples, also from the camel market, gave OD values 
corresponding to 0.79 and 0.116 with corresponding percent inhibition values of 
50 and 7. They were also considered suspected as being positive for BVDV, and 
were reanalysed for confirmation with the VN test at SVA laboratories: all results 
were confirmed as negative. 
 
Discussion  
 This study was designed to determine the occurrence of antibodies to Brucella 
abortus, BVDV and BHV-1 in camels from the Al-Ain region in the UAE. As 
camels are reared together with ruminants (cattle, sheep and goats), collecting data 
on the prevalence of these diseases is important not only for the economic impact 
of the diseases but also because the camels are a source of food, and in the case of 
brucellosis, because of the zoonotic nature of the disease. 
 After confirmation of suspected results in some samples, no antibodies to B. 
abortus, BVDV or BHV-1 were detected in the 812 serum samples, despite the 
serum samples being collected from animals of different ages, sex, and husbandry 
systems.  
 Previous studies on camel brucellosis in the Al-Ain region have shown a 
declining prevalence of the disease. During the period 1990-1996, Moustafa et al 
(1998) reported a gradual reduction of the prevalence of brucellosis from 5.8% in 
1990 to 0.1% in 1996: this was considered due to the reduction in the prevalence 
of the disease in other ruminants. In a study by Afzal & Sakkir (1994), the 
decrease in prevalence of brucellosis was attributed to age in a majority of camels 
in the Al-Ain region, as they are no longer used for breeding; however, Fazil & 
Hofmann (1981) consider it the spontaneous recovery occasionally reported in 
non-breeding female camels.  
 The results in this study agreed with those published in the Annual Bulletin of 
Al-Ain Department of Agriculture and Animal Resources (2002), where no cases 
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of brucellosis were reported in the 1187 samples tested during the period 2001-
2002. A few investigations have revealed a prevalence of 1.5% in camels in the 
Abu Dhabi area and 2% in free grazing dromedaries and 6% in racing dromedaries 
in the whole country. These findings were attributed to the fact that racing camels 
are fed with un-pasteurised dairy cattle milk (Afzal & Sakkir, 1994; Wernery & 
Wernery, 1990). Although the assessment of the prevalence based on age and sex, 
is beyond the scope of this survey, the findings agreed with the results obtained by 
Radwan et al (1992), who report no difference in the prevalence of brucellosis 
among male and female camels. However, the results did not reveal any 
differences in brucellosis occurrence among the sampled animals, and diverged 
with the findings of other authors who indicated an influence of husbandry 
systems upon prevalence that was rather high in the intensively reared camel 
production (Radostits et al., 1994; Teshome et al., 2003). 
 
 The C-ELISA used in this study was based on a monoclonal antibody against a 
single antigen epitope and therefore enhanced sensitivity. The partial and very low 
competition, reflected in 66 samples  (percent inhibition 20-25), could be 
attributed to sub-optimal infectious doses of the pathogen, or due to varying stages 
of infection, where low avidity antibodies produced early during the primary 
immune response, were not able to compete with the monoclonal antibodies or 
with cross reacting ones. Despite the results obtained, the incidence of “Malta 
Fever” among individuals working with camels is common, and cases of sporadic 
abortion in camels raised in close contact with other ruminants are still reported in 
the area, although, the source of both human and camel infection was unclear. 
This could be by people acquiring the infection from other sources, and the cases 
of abortion in camels could be caused by other organisms or factors not covered 
by this study.  
 
 BVDV infections in cattle have an impact on the economy of the farmers; thus, 
is essential to include camels in the animal health monitoring programmes of the 
country, not only because cattle and sheep are the natural hosts for BVDV, but 
also because other animal species are in contact with them or are raised in the 
same vicinity. ELISA has excellent specificity and sensitivity for detecting of 
BVDV antibodies and a close agreement with VN in bovine sera as reported by 
Abd-Elhakim (2004). The convenient technical features, adaptability for 
automation, and rapid results, are other advantages that favour the application of 
ELISA for screening large numbers of samples, compared to the expensive culture 
systems, and time consuming work needed in VN (Evermann, et al., 1993; Chu et 
al., 1985; Howard et al., 1985). 
 
In two surveys on dromedaries in Sudan (see Table 2), the prevalence of BVDV 
was found to be 15.5% in 1987 and 15.7% in 1989 (Bornstein & Musa 1987; 
Bornstein et al., 1989). In other studies, the prevalence of BVDV was 3.9% in 
Tunisia (Burgemeister et al., 1975, 6.7% in Oman (Hedger et al., 1980), and 3.4% 
in Somalia (Bornstein, 1988). In the UAE, Wernery & Wernery (1990) reported a 
prevalence of 3.6%.  In serum samples of 552 racing and breeding camels, a 
prevalence of 6.4% was recorded for breeding camels and only 0.5% for racing 
dromedaries: this prevalence pattern was attributed to the densely crowded 
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breeding herds closely located to cattle herds. Reports from Egypt present a range 
of rates: 11% (Hegazy et al., 1993), 4.3% (Tantawi et al., 1994) and 52.5%, which 
is an extremely high prevalence: no explanation on these results are given 
(Zaghana, 1998). 
 
 The detection of antibodies against BHV-1 in camelids difficulties problematic, 
even in experimentally induced infection, and serocoversion was not always 
observed (Wernery & Kaaden, 1995). The results presented here are in agreement 
with the findings of Paling et al. (1979), Agrimi, et al. (1982), Bornstein & Musa 
(1987), Bornstein (1988), and Wernery & Wernery (1990), where no specific 
antibodies against BHV-1 were detected. Contrary to the results observed in 
OWC, evidence of BHV-1 isolation and seroconversion in NWC has been 
reported by Rivera (1987), Picton (1993), Rosadio et al. (1993) and Mattson 
(1994). Moreover, Wernery & Kaaden (1995) reported a prevalence of 16.2% in 
Peruvian alpacas, which declined to 5.1% in subsequent years when a change in 
production systems was introduced and the animals were reared in separate 
pastures not shared with other ruminants. If these finding are to be generalized, the 
close contact between camel and cattle herds supports the inter-species 
transmission of viral infection. 
 
 Although C-ELISA and B-ELISA were applied for the first time for the 
screening of camel sera for antibodies against the three pathogens, the techniques 
displayed excellent agreement with the corresponding gold standard tests (CFT 
and VN). Thus, ELISA is reliable as a single technique for the detection of 
antibodies to B. abortus, BVDV and BHV-1 antibodies in camels; although, 
reliability would be enhanced if the technique were used in combination with 
conventional techniques such as IHC.  
 
 Finally, the current study was limited due to the difficulties faced during the 
sampling. The ultimate consequence of the results obtained cannot be easily 
predicted. For a better understanding of the importance of brucellosis, BVDV and 
BHV-1 in the whole country in general and in areas of low prevalence in 
particular, a wider study is recommended. 
 
Table 1. Prevalence of brucellosis in camels in various countries (performed by 
Complement Fixation Test).  
 
Country Prevalence% References 
Egypt 23.1 Nada 1984  
Sudan  8 Osman & Adlan 1987 
Somalia 5.9 Bornstein et al., 1988 
Kenya 14.0 Waghela et al., 1978 
Mongolia 1-3.7 Shumilov 1974 
Niger 8.3 Bornarel & Akakpo 1982 
Libya 4.1 Gameel et al., 1993 
Iran 8 Zowghi & Ebadi 1988 
Saudi Arabia 8 Radawan et al., 1995 
Kuwait 14.8 Al-Khalaf & El-Khaladi 1989 
Oman 3.6 Harby & Ismaily 1995 
 
 
 
Table 2. Prevalence of BVDV in camelids from the Old (OWC) and New World, (NWC). 
 
Countries Camels Prevalence % References 
Sudan OWC 15.5  
15.7 
Bornstein & Musa 1987 
Bornstein et al., 1989 
Tunisia OWC 3.9 Burgemeister et al., 
Oman OWC 6.7 Hedger et al., 1980 
Somalia OWC 3.4 Bornstein, 1988 
UAE OWC  9.2-3.6 
6.4 - 0.5 
Wernery & Wernery 1990 
1998  DCVRL* 
Egypt OWC 11-23 
4.3 
52.5 
Hegazy et al., 1993 
Tantawi et al., 1994 
Zaghhana 1998 
USA NWC 4.4 Mattson, 1994 
Peru NWC 11.11 Rivera et al., 1987 
Argentina NWC 2.05 Puntel  et al., 1999 
 
*Dubai Central Veterinary Research Laboratory. 
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Table 3. Origin, sex, and total numbers of sampled animals. 
 
Place Males Females Total 
Abattoir 392 14 406 
Camels market 108 102 210 
Private farms 111 85 196 
Total 611 192 812 
 
 
Table 4. Validation criteria for C-ELISA (B. abortus) and B-ELISA (BVDV and BHV-1).  
 
 Pathogens B. abortus (C-ELISA) BVDV (B-ELISA)   BHV-1 (B-ELISA) 
Validation 
criteria 
for controls 
OD for CCs 0.75-2.0   
PI for PC 90-110  
OD, NC >0.800 
PC, PI <20% 
OD, NC >0.800 
PC, PI <30% 
Inter- 
pretation  
of results  
PI= 90 -110 positive 
PI= 35-65 weak positive 
PI= 10-15 negative 
PI >50% negative 
PI 40%-50% doubtful  
PI <40% positive 
PI >55% negative 
PI 50-55% doubtful 
PI <50% positive 
 
OD= Optical density; PI= percent inhibition; CCs= controls; NC= negative control; PC= 
positive control. 
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